Last reviewed · How we verify

NCT03690505: DEMELE

Assessment of the Knowledge and Needs of Patients With AMD Before a Therapeutic Patient Education Program is Put in Place

Status unknown NA Last updated 28 June 2019
What this trial tests

NA trial testing Interviews in Age-related Macular Degeneration (AMD) in 200 participants. Status unknown.

Timeline
12 March 2019
Primary endpoint
1 October 2020
1 January 2021

Quick facts

Lead sponsorUniversity Hospital, Limoges
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment200
Start date12 March 2019
Primary completion1 October 2020
Estimated completion1 January 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Limoges

Who can join

50 Months and older, any sex, with Age-related Macular Degeneration (AMD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for "straight-ahead" activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail The purpose of the study is to describe in patients with AMD and depending on the nature of their pathology (neovascular or atrophic): (i) knowledge about their pathology (risk factors, symptoms, treatments, self-monitoring tool), (ii) their needs and (iii) impact on their daily lives This study is to make an inventory of the knowledge of patients with AMD about their disease and risk factors using a questionnaire (Appendix 1) and to identify their needs, the impact of the disease on their daily lives during individual interviews by raising the recurrent data and confronting them during the focus group. The information gathered will enable the construction of a therapeutic education program for better patient care and to strengthen the patient's capacities so that he becomes an actor in his change throughout his care project. This a 3 steps study: 1. 200 patients will be enrolled and answer a questionnaire on knowledge of the disease 2. Two groups of 20 patients will be selected to participate to a semi-structured individual interviews 3. Two focus groups of 10 patients will be organized to assess needs, expectations, satisfactions or to better understand opinions, motivations or behaviors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Interviews

Trials testing the same drug.

Other recruiting trials for Age-related Macular Degeneration (AMD)

Currently open trials in the same condition.

Other University Hospital, Limoges trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03690505.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing